Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 132

1.

Polymorphisms of insulin degrading enzyme gene are not associated with Alzheimer's disease.

Boussaha M, Hannequin D, Verpillat P, Brice A, Frebourg T, Campion D.

Neurosci Lett. 2002 Aug 23;329(1):121-3.

PMID:
12161276
2.

Insulin-degrading enzyme and Alzheimer disease: a genetic association study in the Han Chinese.

Bian L, Yang JD, Guo TW, Sun Y, Duan SW, Chen WY, Pan YX, Feng GY, He L.

Neurology. 2004 Jul 27;63(2):241-5.

PMID:
15277615
3.

No association between the insulin degrading enzyme gene and Alzheimer's disease in a Japanese population.

Sakai A, Ujike H, Nakata K, Takehisa Y, Imamura T, Uchida N, Kanzaki A, Yamamoto M, Fujisawa Y, Okumura K, Kuroda S.

Am J Med Genet B Neuropsychiatr Genet. 2004 Feb 15;125B(1):87-91.

PMID:
14755451
4.

Combined risk effects of IDE and NEP gene variants on Alzheimer disease.

Vepsäläinen S, Helisalmi S, Mannermaa A, Pirttilä T, Soininen H, Hiltunen M.

J Neurol Neurosurg Psychiatry. 2009 Nov;80(11):1268-70. doi: 10.1136/jnnp.2008.160002.

PMID:
19864659
5.

Positive association between risk for late-onset Alzheimer disease and genetic variation in IDE.

Björk BF, Katzov H, Kehoe P, Fratiglioni L, Winblad B, Prince JA, Graff C.

Neurobiol Aging. 2007 Sep;28(9):1374-80.

PMID:
16876916
6.

Insulin-degrading enzyme, apolipoprotein E, and Alzheimer's disease.

Edland SD.

J Mol Neurosci. 2004;23(3):213-7.

PMID:
15181249
7.
8.

Insulin degrading enzyme (IDE) genetic variants and risk of Alzheimer's disease: evidence of effect modification by apolipoprotein E (APOE).

Edland SD, Wavrant-De Vriesé F, Compton D, Smith GE, Ivnik R, Boeve BF, Tangalos EG, Petersen RC.

Neurosci Lett. 2003 Jul 10;345(1):21-4.

PMID:
12809979
9.

Substantial linkage disequilibrium across the insulin-degrading enzyme locus but no association with late-onset Alzheimer's disease.

Abraham R, Myers A, Wavrant-DeVrieze F, Hamshere ML, Thomas HV, Marshall H, Compton D, Spurlock G, Turic D, Hoogendoorn B, Kwon JM, Petersen RC, Tangalos E, Norton J, Morris JC, Bullock R, Liolitsa D, Lovestone S, Hardy J, Goate A, O'Donovan M, Williams J, Owen MJ, Jones L.

Hum Genet. 2001 Dec;109(6):646-52.

PMID:
11810277
10.

Insulin-degrading enzyme is genetically associated with Alzheimer's disease in the Finnish population.

Vepsäläinen S, Parkinson M, Helisalmi S, Mannermaa A, Soininen H, Tanzi RE, Bertram L, Hiltunen M.

J Med Genet. 2007 Sep;44(9):606-8.

11.

Weak independent association signals between IDE polymorphisms, Alzheimer's disease and cognitive measures.

Mueller JC, Riemenschneider M, Schoepfer-Wendels A, Gohlke H, Konta L, Friedrich P, Illig T, Laws SM, Förstl H, Kurz A.

Neurobiol Aging. 2007 May;28(5):727-34.

PMID:
16675064
12.

Association studies testing for risk for late-onset Alzheimer's disease with common variants in the beta-amyloid precursor protein (APP).

Nowotny P, Simcock X, Bertelsen S, Hinrichs AL, Kauwe JS, Mayo K, Smemo S, Morris JC, Goate A.

Am J Med Genet B Neuropsychiatr Genet. 2007 Jun 5;144B(4):469-74.

PMID:
17427190
13.

Lack of association between IDE genetic variability and Down's syndrome.

Arpino C, Piciullo A, Palmarino M, Saccucci P, Galasso C, Lucarelli P, Curatolo P.

Neurosci Lett. 2005 Jul 1-8;382(1-2):93-5.

PMID:
15911128
14.

Sequence variants of IDE are associated with the extent of beta-amyloid deposition in the Alzheimer's disease brain.

Blomqvist ME, Chalmers K, Andreasen N, Bogdanovic N, Wilcock GK, Cairns NJ, Feuk L, Brookes AJ, Love S, Blennow K, Kehoe PG, Prince JA.

Neurobiol Aging. 2005 Jun;26(6):795-802.

PMID:
15718037
15.

Exploration of 16 candidate genes identifies the association of IDE with Alzheimer's disease in Han Chinese.

Wang F, Shu C, Jia L, Zuo X, Zhang Y, Zhou A, Qin W, Song H, Wei C, Zhang F, Hong Z, Tang M, Wang DM, Jia J.

Neurobiol Aging. 2012 May;33(5):1014.e1-9. doi: 10.1016/j.neurobiolaging.2010.08.004.

PMID:
20880607
16.

The association between two single nucleotide polymorphisms within the insulin-degrading enzyme gene and Alzheimer's disease in a Chinese Han population.

Cui PJ, Cao L, Wang Y, Deng YL, Xu W, Wang G, Zhang Y, Zheng L, Fei QZ, Zhang T, Chen SD.

J Clin Neurosci. 2012 May;19(5):745-9. doi: 10.1016/j.jocn.2011.08.036.

PMID:
22502914
17.

Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo.

Farris W, Mansourian S, Chang Y, Lindsley L, Eckman EA, Frosch MP, Eckman CB, Tanzi RE, Selkoe DJ, Guenette S.

Proc Natl Acad Sci U S A. 2003 Apr 1;100(7):4162-7.

18.

PSEN1 polymorphisms alter the rate of cognitive decline in sporadic Alzheimer's disease patients.

Belbin O, Beaumont H, Warden D, Smith AD, Kalsheker N, Morgan K.

Neurobiol Aging. 2009 Dec;30(12):1992-9. doi: 10.1016/j.neurobiolaging.2008.02.013.

PMID:
18403054
19.

Promoter polymorphisms which modulate insulin degrading enzyme expression may increase susceptibility to Alzheimer's disease.

Zuo X, Jia J.

Brain Res. 2009 Jan 16;1249:1-8. doi: 10.1016/j.brainres.2008.10.034.

PMID:
18996360
20.

Dynamin-binding protein gene on chromosome 10q is associated with late-onset Alzheimer's disease.

Kuwano R, Miyashita A, Arai H, Asada T, Imagawa M, Shoji M, Higuchi S, Urakami K, Kakita A, Takahashi H, Tsukie T, Toyabe S, Akazawa K, Kanazawa I, Ihara Y; Japanese Genetic Study Consortium for Alzeheimer's Disease..

Hum Mol Genet. 2006 Jul 1;15(13):2170-82.

PMID:
16740596
Items per page

Supplemental Content

Support Center